Yoong Ying Tan
Fortune : 26 554 $ au 30/06/2026
Fortune : 26 554 $ au 30/06/2026
Yoong Ying Tan is Director at Advance Cancer Centre Pte Ltd. since 2020.
Ms. Tan is Director at Puricell Lab Pte Ltd. since 2020.
Formerly, Ms. Tan was Director at Advantage Mining Sdn.
Bhd.
from 2016 to 2018.
Ms. Tan was Manager-Development at Pulai Mining Sdn.
from 2014 to 2017.
Education includes a graduate degree from the University of Aberdeen in 2012, an undergraduate degree from Jinan University in 2011, and a graduate degree from BPP Law School in 2014.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/03/2026 | 25 781 ( 0,22% ) | 26 554 $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| CYTOMED THERAPEUTICS LIMITED | Corporate Officer/Principal | 01/06/2018 |
Puricell Lab Pte Ltd. | Directeur/Membre du Conseil | 01/10/2020 |
Advance Cancer Centre Pte Ltd. | Directeur/Membre du Conseil | 01/02/2020 |
| Sociétés | Poste | Fin |
|---|---|---|
Pulai Mining Sdn. Bhd.
Pulai Mining Sdn. Bhd. Precious MetalsNon-Energy Minerals Engages in exploration and mining of gold and other minerals | Corporate Officer/Principal | 01/03/2017 |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 7 |
|---|---|
University of Aberdeen
University of Aberdeen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Jinan University
Jinan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BPP Law School
BPP Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pulai Mining Sdn. Bhd.
Pulai Mining Sdn. Bhd. Precious MetalsNon-Energy Minerals Engages in exploration and mining of gold and other minerals | Non-Energy Minerals |
CytoMed Therapeutics Ltd.
CytoMed Therapeutics Ltd. BiotechnologyHealth Technology Operates as a pre-clinical biopharmaceutical company that focuses on harnessing licensed proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers | Health Technology |
Advance Cancer Centre Pte Ltd. | |
Puricell Lab Pte Ltd. |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national